During the past decade, Ochsner LSU Health Monroe Medical Center conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 26 clinical trials were completed, i.e. on average, 78.8% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 13 clinical trials were completed. i.e. 86.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ochsner LSU Health Monroe Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored and "Eastern Cooperative Oncology Group" with 7 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ochsner LSU Health Monroe Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "Eastern Cooperative Oncology Group" with 6 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Ochsner LSU Health Monroe Medical Center" are "Lung Cancer" (5 trials), "Lymphoma" (5 trials), "Recurrent Melanoma" (5 trials), "Breast Cancer" (4 trials) and "Leukemia" (4 trials). Many other conditions were trialed in "Ochsner LSU Health Monroe Medical Center" in a lesser frequency.

Most popular intervention types in "Ochsner LSU Health Monroe Medical Center" are "Drug" (56 trials), "Other" (50 trials), "Biological" (30 trials), "Procedure" (16 trials) and "Dietary Supplement" (4 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (19 trials), "Laboratory Biomarker Analysis" (16 trials), "Biospecimen Collection" (11 trials), "Computed Tomography" (9 trials) and "Cyclophosphamide" (8 trials). Other intervention names were less common.

The vast majority of trials in "Ochsner LSU Health Monroe Medical Center" are 67 trials for "All" genders, 8 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ochsner LSU Health Monroe Medical Center". undefined are not yet recruiting, 16 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Ochsner LSU Health Monroe Medical Center, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Ochsner LSU Health Monroe Medical Center, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".